ProMIS Neurosciences Inc. - PMN
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 18, 2026 | SCHEDULE 13G | Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. | 9.99% | 895,877 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Great Point Partners, LLC | 9.99% | 409,648 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Dr. Jeffrey R. Jay, M.D. | 9.99% | 409,648 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Ms. Lillian Nordahl | 9.99% | 409,648 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Armistice Capital, LLC | 0.93% | 504,673 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Steven Boyd | 0.93% | 504,673 | View |
| Feb 10, 2026 | SCHEDULE 13G | Trails Edge Capital Partners, LP | 9.9% | 933,477 | View |
| Feb 10, 2026 | SCHEDULE 13G | Trails Edge Biotechnology Master Fund, LP | 9.9% | 933,477 | View |
| Feb 10, 2026 | SCHEDULE 13G | Ortav Yehudai | 9.9% | 933,477 | View |
| Feb 06, 2026 | SCHEDULE 13G | Deep Track Capital, LP | 9.99% | 902,561 | View |
| Feb 06, 2026 | SCHEDULE 13G | Deep Track Biotechnology Master Fund, Ltd. | 7.79% | 703,457 | View |
| Feb 06, 2026 | SCHEDULE 13G | David Kroin | 9.99% | 902,561 | View |
| Feb 06, 2026 | SCHEDULE 13G | Deep Track Special Opportunities Fund, LP. | 2.2% | 199,104 | View |
| Feb 05, 2026 | SCHEDULE 13D/A | — | — | 407,230 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Sphera Funds Management Ltd. | 7.78% | 180,698 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Sphera Global Healthcare GP Ltd. | 7.78% | 180,698 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Sphera Global Healthcare Management LP. | 7.78% | 180,698 | View |
| Feb 02, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Armistice Capital, LLC | 5.53% | 2,974,518 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Steven Boyd | 5.53% | 2,974,518 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Great Point Partners, LLC | 9.99% | 5,972,369 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Dr. Jeffrey R. Jay, M.D. | 9.99% | 5,972,369 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Ms. Lillian Nordahl | 9.99% | 5,972,369 | View |
| Oct 29, 2025 | SCHEDULE 13D | — | — | 6,058,738 | View |
| Oct 23, 2025 | SCHEDULE 13G/A | Sphera Funds Management Ltd. | 5.51% | 3,122,090 | View |
| Oct 23, 2025 | SCHEDULE 13G/A | Sphera Global Healthcare GP Ltd. | 5.51% | 3,122,090 | View |
| Oct 23, 2025 | SCHEDULE 13G/A | Sphera Global Healthcare Management LP. | 5.51% | 3,122,090 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.